| Application no. and date | 19815892.5 (espacenet) (Federated) (European Patent Register), 20190607 | | Patent/reg. no. and date | DK/EP 3813816, 20230607 | | Publication date | 20210505 | | Priority no. and date | US 201862681913 P, 20180607 | | EP pub. no. and date |
EP 3813816 20210505 | | Effective date | | | Applicant/owner | Ovid Therapeutics Inc., 441 9th Avenue,
New York, NY 10001, US | | Applicant ref. no. | | | Inventor | DURING, Matthew, 14 Cedar Lane
Weston, Connecticut 06883, US,
ABRAHAMS, Brett, 324 East 41st Street
New York, New York 10017, US | | Representative | | | Opponent | | | IPC Class | A61K 31/00 (2006.01) , A61K 31/185 (2006.01) , A61K 31/19 (2006.01) , A61K 31/196 (2006.01) , A61P 25/00 (2006.01) | | Title | USE OF (S)-3-AMINO-4-(DIFLUOROMETHYLENYL) CYCLOPENT-1-ENE-1-CARBOXYLIC ACID AND RELATED COMPOUNDS, (1S,3S)-3-AMINO-4-(DIFLUOROMETHYLIDENE) CYCLOPENTANE-1-CARBOXYLIC ACID AND VIGABATRIN IN THE TREATMENT OF DEVELOPMENTAL DISORDERS | | Int. application no. | US2019035934 | | Int. publication no. | WO2019236938 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
